Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Specialty Devices
Drug Delivery Devices
Return to: MDBR Home | Specialty Devices | Drug Delivery Devices

Drug Delivery Devices

Medtronic gets Japanese regulatory approval for IN.PACT admiral drug-coated balloon Medtronic announced that the IN.PACT admiral drug-coated balloon (DCB) received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for the treatment of peripheral artery disease (PAD) in the upper leg - specifically, in the thigh (superficial femoral arteries (SFA)) and behind the knee (popliteal arteries).
Specialty Devices > Drug Delivery Devices > News
FDA grants OTC clearance for ABMC’s Rapid TOX Cup II American Bio Medica (ABMC) announced that the US Food and Drug Administration (FDA) has granted 510(k) marketing clearance for over-the-counter use to the company's Rapid TOX Cup II drug test product line.
Specialty Devices > Drug Delivery Devices > News Surmodics secures IDE approval to start trial of SurVeil drug-coated balloon Surmodics has received an investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA) to initiate a pivotal clinical trial of the SurVeil™ drug-coated balloon (DCB).
Specialty Devices > Drug Delivery Devices > News
See more Drug Delivery Devices news

Latest Drug Delivery Devices News and Insight

View all Drug Delivery Devices news or find news targeted to your interests
Lubrizol LifeSciences Announces $10 Million Vesta Expansion
Lubrizol LifeSciences is investing $10 million for a significant capacity expansion at its silicone contract manufacturing site in Franklin, WI.
Specialty Devices > Drug Delivery Devices > Press Releases
FDA grants OTC clearance for ABMC’s Rapid TOX Cup II
American Bio Medica (ABMC) announced that the US Food and Drug Administration (FDA) has granted 510(k) marketing clearance for over-the-counter use to the company's Rapid TOX Cup II drug test product line.
Specialty Devices > Drug Delivery Devices > News
Surmodics secures IDE approval to start trial of SurVeil drug-coated balloon
Surmodics has received an investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA) to initiate a pivotal clinical trial of the SurVeil™ drug-coated balloon (DCB).
Specialty Devices > Drug Delivery Devices > News
View all Drug Delivery Devices news or find news targeted to your interests